57 related articles for article (PubMed ID: 3074153)
1. Complement pathway activity in the opsonization of cefotaxime-treated Escherichia coli by normal human serum.
Shaio MF; Chang FY; Chou MY
Taiwan Yi Xue Hui Za Zhi; 1988 Jul; 87(7):712-20. PubMed ID: 3074153
[No Abstract] [Full Text] [Related]
2. Complement pathway activity in the opsonization of mutant strains of Salmonella typhimurium.
Shaio MF; Rowland H
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 May; 19(2):137-52. PubMed ID: 3102176
[TBL] [Abstract][Full Text] [Related]
3. Amplification of the classical complement pathway by the venom of the Mojave rattlesnake (Crotalus scutulatus scutulatus).
Rathbun G; Rael ED; Paquet A; Marquez L
Toxicon; 1980; 18(5-6):625-31. PubMed ID: 7222067
[No Abstract] [Full Text] [Related]
4. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin-independent utilization of the classical complement pathway in opsonophagocytosis of Escherichia coli by human peripheral leukocytes.
Leist-Welsh P; Bjornson AB
J Immunol; 1982 Jun; 128(6):2643-51. PubMed ID: 6210733
[No Abstract] [Full Text] [Related]
6. Inhibitory activity of Jatropha multifida latex on classical complement pathway activity in human serum mediated by a calcium-binding proanthocyanidin.
Kosasi S; Hart LA; van Dijk H; Labadie RP
J Ethnopharmacol; 1989 Nov; 27(1-2):81-9. PubMed ID: 2615430
[TBL] [Abstract][Full Text] [Related]
7. Opsonization of various capsular (K) E. coli by the alternative complement pathway.
Stevens P; Young LS; Adamu S
Immunology; 1983 Nov; 50(3):497-502. PubMed ID: 6354922
[TBL] [Abstract][Full Text] [Related]
8. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.
Levy NJ; Kasper DL
J Immunol; 1986 Jun; 136(11):4157-62. PubMed ID: 3517165
[TBL] [Abstract][Full Text] [Related]
9. Effect of concanavalin A on the hemolytic activity of the components of the classical complement pathway.
Gee AP; Boyle MD; Langone JJ
Mol Immunol; 1980 Jan; 17(1):143-6. PubMed ID: 7360112
[No Abstract] [Full Text] [Related]
10. Effect of a streptococcal preparation on the complement system.
Kato H; Yokoe N; Matsumura N; Nishida K; Ikezaki M; Hosokawa K; Hotta T; Takemura S; Yoshikawa T; Kondo M
Jpn J Exp Med; 1979 Oct; 49(5):343-50. PubMed ID: 529490
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological modulation of complement system: proposition of anticomplement therapy].
Yamauchi Y
Nihon Rinsho; 1981 Apr; 39(4):1791-800. PubMed ID: 7031292
[No Abstract] [Full Text] [Related]
12. Action of a new non-steroid anti-inflammatory drug, carprofen (Ro 20-5720) on activation of the complement system: an in vitro research.
Auteria A; Laghi Pasini F; Di Perri T
Int J Tissue React; 1982; 4(1):9-13. PubMed ID: 7085003
[TBL] [Abstract][Full Text] [Related]
13. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
Giclas PC
J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
[TBL] [Abstract][Full Text] [Related]
14. Influence of a bagasse glucan (B0) on leukocyte aggregation and accumulation.
Li XY; Damerau B; Vogt W
Zhongguo Yao Li Xue Bao; 1985 Jun; 6(2):137-40. PubMed ID: 2934950
[No Abstract] [Full Text] [Related]
15. Synergistic effect of cefotaxime and normal human serum on bactericidal activity against urinary strains of Escherichia coli with capsular antigen K1.
Franiczek R; Jankowski S
Acta Microbiol Pol; 1993; 42(3-4):243-50. PubMed ID: 7516615
[TBL] [Abstract][Full Text] [Related]
16. [Alternative complement activation pathway. Its mechanism, importance and quantitative determination].
Gancevici GG; Popescu C
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(3):209-21. PubMed ID: 6390651
[No Abstract] [Full Text] [Related]
17. Salt-sensitivity of complement (C)-consumption induced by anticomplementary antigens and antigen/antibody complexes.
Gancevici G; Popescu C; Toporan M
Arch Roum Pathol Exp Microbiol; 1982; 41(3):239-50. PubMed ID: 6818928
[No Abstract] [Full Text] [Related]
18. Analysis of complement activation profile during cardiopulmonary bypass and its inhibition by FUT-175.
Miyamoto Y; Hirose H; Matsuda H; Nakano S; Ohtani M; Kaneko M; Nishigaki K; Nomura F; Kitamura H; Kawashima Y
Trans Am Soc Artif Intern Organs; 1985; 31():508-11. PubMed ID: 3837498
[No Abstract] [Full Text] [Related]
19. Dapsone and complement.
Schifferli JA; Jones RR
Lancet; 1981 Aug; 2(8242):368-9. PubMed ID: 6115143
[No Abstract] [Full Text] [Related]
20. In vitro effects of organic solvents on immunity indicators in serum.
Stefanovic J; Starsia Z; Murgasová I; Absolonová O
J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):1-7. PubMed ID: 3571967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
